Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| METTL3 relieved the injury of SH-SY5Y cells treated with lipopolysaccharide and exposed to sevoflurane through regulating the m6A levels of Sox2. | Brain Behav | 2023 | 36977205 | PubTator, text mining | PubMed |
| Identification of m6A-associated LncRNAs as predict factors for the immune infiltration and prognosis of thyroid cancer. | Ann Med | 2023 | 36974635 | PubTator, text mining | PubMed |
| Rewired m6A epitranscriptomic networks link mutant p53 to neoplastic transformation. | Nat Commun | 2023 | 36973285 | PubTator, text mining | PubMed |
| Bibliometric analysis of METTL3: Current perspectives, highlights, and trending topics. | Open Life Sci | 2023 | 36970605 | PubTator, text mining | PubMed |
| The emerging role of long non-coding RNAs in renal cell carcinoma progression and clinical therapy via targeting metabolic regulation. | Front Pharmacol | 2023 | 36969848 | PubTator, text mining | PubMed |
| DNA G-Quadruplex-Binding Protein Developed Using the RGG Domain of Translocated in Liposarcoma/Fused in Sarcoma Inhibits Transcription of bcl-2. | ACS Omega | 2023 | 36969440 | PubTator, text mining | PubMed |
| The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer. | Front Oncol | 2023 | 36969033 | PubTator, text mining | PubMed |
| Editorial: RNA and RNA modification in the pathogenesis, diagnosis and treatment of cancers, Volume II. | Front Oncol | 2023 | 36968996 | PubTator, text mining | PubMed |
| PHF6 recruits BPTF to promote HIF-dependent pathway and progression in YAP-high breast cancer. | J Transl Med | 2023 | 36967443 | PubTator, text mining | PubMed |
| The function and mechanisms of action of circular RNAs in Urologic Cancer. | Mol Cancer | 2023 | 36966306 | PubTator, text mining | PubMed |
| High expression of WTAP is related to poor prognosis in nasopharyngeal carcinoma. | Neoplasma | 2023 | 36964720 | PubTator, text mining | PubMed |
| The m6A reader PRRC2A is essential for meiosis I completion during spermatogenesis. | Nat Commun | 2023 | 36964127 | PubTator, text mining | PubMed |
| METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS. | Oncol Rep | 2023 | 36960869 | PubTator, text mining | PubMed |
| Roles and therapeutic implications of m6A modification in cancer immunotherapy. | Front Immunol | 2023 | 36960074 | PubTator, text mining | PubMed |
| METTL3-mediated m6A modification of HMGA2 mRNA promotes subretinal fibrosis and epithelial-mesenchymal transition. | J Mol Cell Biol | 2023 | 36945110 | PubTator, text mining | PubMed |
| Establishing a prognostic model of chromatin modulators and identifying potential drug candidates in renal clear cell patients. | BMC Bioinformatics | 2023 | 36941564 | PubTator, text mining | PubMed |
| The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response. | Cancer Res | 2023 | 36939388 | PubTator, text mining | PubMed |
| Effect of N6-methyladenosine methylation-related gene signature for predicting the prognosis of hepatocellular carcinoma patients. | Front Surg | 2023 | 36936652 | PubTator, text mining | PubMed |
| N6-methyladenosine related gene expression signatures for predicting the overall survival and immune responses of patients with colorectal cancer. | Front Genet | 2023 | 36936424 | PubTator, text mining | PubMed |
| Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer. | BMC Bioinformatics | 2023 | 36935487 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=64